Allylestrenol-Impurities | Pharmaffiliates

allylestrenol and its Impurities

Allylestrenol is used in the treatment of recurrent and threatened miscarriage and to prevent premature labor. It is also used in Japan to treat benign prostatic hyperplasia in men. Allylestrenol was first described in 1958 and was introduced for medical use by 1961. Reference standards of Allylestrenol API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 3 results for allylestrenol Impurities
PA 28 98000

Allylestrenol - API Standards

Allylestrenol


  • Catalogue No.:PA 28 98000

  • CAS :

    432-60-0

  • Molecular Formula : C21H32O

  • Molecular Weight : 300.48

PA 28 0981000

Estrenone

Estrenone


  • Catalogue No.:PA 28 0981000

  • CAS :

    3646-28-4

  • Molecular Formula : C18H26O

  • Molecular Weight : 258.41

PA 28 0981001

(13S,16R,17S)-16-Allyl-13-methyl-2,6,7,8,9,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol

(13S,16R,17S)-16-Allyl-13-methyl-2,6,7,8,9,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol


  • Catalogue No.:PA 28 0981001

  • CAS :

    N/A

  • Molecular Formula : C21H30O

  • Molecular Weight : 298.47